Virtual reality training for improving cognition in Alzheimer's patients
The Effectiveness of Virtual Reality Training Program in Community Dwelling Older Adults With Alzheimer's Disease
NA · Yeditepe University · NCT06575218
This study is testing if a virtual reality training program can help improve thinking skills in people with Alzheimer's disease compared to traditional exercises and balance activities.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 45 (estimated) |
| Ages | 55 Years to 90 Years |
| Sex | All |
| Sponsor | Yeditepe University (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06575218 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a Virtual Reality Training Program aimed at enhancing cognitive function in individuals diagnosed with Alzheimer's disease. Participants aged 55 and older will be randomly assigned to one of three groups: those receiving virtual reality training, those engaging in traditional cognitive exercises, and a control group performing only balance exercises. The study employs a prospective randomized controlled design to assess the impact of these interventions on cognitive outcomes. The goal is to determine if VR technology can provide a beneficial rehabilitation tool for Alzheimer's patients living in the community.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 55 and older who have been diagnosed with Alzheimer's disease and meet specific cognitive criteria.
Not a fit: Patients with significant mobility restrictions or severe sensory impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could improve cognitive function and quality of life for patients with Alzheimer's disease.
How similar studies have performed: While the use of virtual reality in rehabilitation is gaining interest, this specific application for Alzheimer's disease is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 55 years and older Diagnosed with AD according to DSM-IV diagnostic criteria by a neurologist, MOCA ≥ 16 Clinical Dementia Rating Scale \< 2 Exclusion Criteria: * Various mobility restrictions, musculoskeletal disorders, (wheelchair use, etc.) Clinically significant aphasia (must be able to understand the therapist's commands) Significant visual or sensory impairment
Where this trial is running
Istanbul
- Ebru Akbuğa Koç — Istanbul, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: Ebru Akbuga Koc
- Email: ebru.akbuga@yeditepe.edu.tr
- Phone: 216
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Alzheimer Disease